Cell Design Labs
2015
FOUNDED
M&A
STATUS
1-10
EMPLOYEES
M&A
LATEST DEAL TYPE
$567M
LATEST DEAL AMOUNT
1
INVESTORS
Description
Developer of cell-based disruptive therapies designed to offer treatment for cancer and other devastating diseases. The company's therapies include disruptive T cell receptor therapies that modifies the body's immune cells to create therapeutic agents capable of selectively recognizing, disabling and destroying malignant threats, enabling medical researchers to develop cell-based therapies efficiently.
Primary Office
- 5858 Horton Street
- Suite 240
- Emeryville, CA 94608
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Cell Design Labs’s full profile, request a free trial.
Cell Design Labs Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 01-Dec-2017 | $567M | 000.00 | 00000 | Completed | Generating Revenue |
| 4. Accelerator/Incubator | 02-Feb-2017 | 000.00 | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series C) | 16-Jun-2016 | 000 | 000.00 | 0000 | Completed | Generating Revenue |
| 2. Early Stage VC (Series B) | 21-Dec-2015 | $22.9M | $30.7M | 000.00 | Completed | Generating Revenue |
| 1. Early Stage VC (Series A) | $7.8M | $7.8M | 000.00 | Completed | Generating Revenue |
Cell Design Labs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | 0,000,000 | 00.000000 | 00 | 00.0 | 00.0 | 00 | 00.0 | 0.000 |
| Series B | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A | 3,900,940 | $0.000100 | 6% | $2 | $2 | 1x | $2 | 24.12% |
Cell Design Labs Competitors (57)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CytImmune | Venture Capital-Backed | Rockville, MD | 000.00 | 0000000000 0 | 000.00 | |
| 00000000 | Venture Capital-Backed | Tübingen, Germany | 000 | 00000 | 00000000000 | 00000 |
| 00000000 | Formerly VC-backed | Munich, Germany | 000.00 | 000000&0 | 000.00 | |
| 0000000000 | Venture Capital-Backed | Abingdon, United Kingdom | 000 | 00000 | 00000000000 | 00000 |
| 000000 | Venture Capital-Backed | Utrecht, Netherlands | 00.000 | 00000000000 | 00.000 |
Cell Design Labs Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Arie Belldegrun | Angel (individual) | Minority | 000 0000 | 000000 0 | ||
| Brian Atwood | Angel (individual) | Minority | 000 0000 | 000000 0 | ||
| California Institute for Quantitative Biosciences | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | ||
| JLABS | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | ||
| Kleiner Perkins | Venture Capital | Minority | 000 0000 | 000000 0 |
Cell Design Labs Executive Team (6)
1 Former Executive
You’re viewing 5 of 6 executives. Get the full list »Cell Design Labs Board Members (7)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Fred Cohen MD | Self | Chairman & Co-Founder | 000 0000 | |
| Wendell Lim Ph.D | Cell Design Labs | Scientific Founder & Board Observer | 000 0000 |
5 Former Board Members
You’re viewing 2 of 7 board members. Get the full list »